In the process, the researchers have discovered a previously unknown population of immune cells in the brains of Alzheimer’s patients, which is found almost exclusively in the vicinity of a specific ...
First Phase III results from the clinical development program QUANTI on investigational MRI contrast agent gadoquatrane presented as late-breaking data during a scientific session at the 2025 European ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results